Key result
Planned PCI around TAVI shows no mortality or major cardiovascular events benefit while increasing major bleeding.
Why the study?
Severe aortic stenosis and coronary artery disease frequently coexist in patients undergoing TAVI, prompting comparison of planned PCI around TAVI against an initially conservative or deferred PCI strategy.
Does planned percutaneous coronary intervention around TAVI reduce all-cause mortality and major adverse cardiovascular events compared with an initially conservative or deferred PCI strategy in patients with severe aortic stenosis and coronary artery disease?
Meta-Analysis (n=1,156)
Does planned percutaneous coronary intervention around TAVI reduce all-cause mortality and major adverse cardiovascular events compared with an initially conservative or deferred PCI strategy in patients with severe aortic stenosis and coronary artery disease?
Routine planned PCI around TAVI does not reduce mortality or major ischemic events compared to a conservative or deferred strategy, though it reduces subsequent revascularizations at the cost of increased bleeding.
Answers are grounded in this paper and cite their sources.
Routine planned PCI around TAVI should be avoided due to net harm from bleeding without ischemic benefit; challenges prior revascularization strategies in severe AS.
BACKGROUND: Severe aortic stenosis and coronary artery disease frequently coexist in patients undergoing transcatheter aortic valve implantation (TAVI). We compared planned percutaneous coronary intervention (PCI) around TAVI with an initially conservative or deferred PCI strategy. METHODS: We searched PubMed, Cochrane, Scopus, and Web of Science through 15 April 2026. Risk ratios with 95% confidence intervals (CIs) were pooled using random-effects models. Exploratory reconstruction was a secondary analysis. The study protocol was prospectively registered in PROSPERO with the following ID: CRD420261397950. RESULTS: Three randomized controlled trials including 1156 patients were identified. Planned PCI was not associated with significant differences in all-cause mortality (risk ratio = 0.90, 95% CI = 0.70-1.15), trial-defined major adverse cardiovascular events (MACE; risk ratio = 0.91, 95% CI = 0.70-1.18; supportive and exploratory because composite components differed), cardiovascular death (risk ratio = 0.74, 95% CI = 0.51-1.08), or myocardial infarction (risk ratio = 0.86, 95% CI = 0.45-1.63). It was associated with fewer urgent (risk ratio = 0.33, 95% CI = 0.13-0.87) and any subsequent revascularizations (risk ratio = 0.25, 95% CI = 0.07-0.87), but more trial-reported major bleeding (risk ratio = 1.57, 95% CI = 1.07-2.32; definitions varied) and any bleeding (risk ratio = 1.77, 95% CI = 1.27-2.47). CONCLUSION: Routine planned PCI around TAVI was not shown to reduce mortality or major ischemic outcomes. It was associated with fewer subsequent revascularizations and more trial-reported major bleeding and any bleeding, supporting selective, individualized decision-making.
No takes yet. Share an insight, caveat, or question.
Gowaily et al. (2026) conducted a meta-analysis in Severe aortic stenosis and coexisting coronary artery disease undergoing transcatheter aortic valve implantation (TAVI) (n=1,156). Planned percutaneous coronary intervention (PCI) around TAVI vs. Initially conservative or deferred PCI strategy was evaluated on All-cause mortality (RR 0.90, 95% CI 0.70-1.15). Planned PCI around TAVI did not reduce all-cause mortality or major cardiovascular events, while increasing major bleeding.
Synapse has enriched 10 related papers. Consider them for comparative context: